Pharmaceutical Industry Update: April–May 2025 Highlights💊🚀

💊Pharma Sector: Cautious Dose of Optimism 📅 April–May 2025 Highlights: - Pharma market up 8.4% YoY in FY25. - Cipla & GSK Pharma posted strong Q4 profits. - FIIs pumped in ₹46,000+ crore in April–May, but pharma got a mixed share. - US drug price reforms = pressure on Indian exports. 🚀 Growth Drivers: -Surge in chronic therapy demand (cardiac, diabetes). -China+1 manufacturing shift benefits India. -Strong R&D and domestic consumption. ⚠️ Risks to Watch: -USFDA actions, price caps, and global policy shifts. -Valuations stretched for some export-heavy names. 🧠 Takeaway: Pharma's long-term story is intact, but near-term volatility demands a stock-specific, balanced approach. Not a sector to overdose on — pick your pills wisely. 💊📊